CN Patent
CN102892407A — 氨磺必利作为止吐药的用途
Assigned to Acacia Pharma Ltd · Expires 2013-01-23 · 13y expired
What this patent protects
氨磺必利用于恶心、呕吐或反胃的治疗。所述治疗可以利用一种单位剂型形式的新型注射制剂,包含少于50mg氨磺必利。
USPTO Abstract
氨磺必利用于恶心、呕吐或反胃的治疗。所述治疗可以利用一种单位剂型形式的新型注射制剂,包含少于50mg氨磺必利。
Drugs covered by this patent
- Barhemsys (AMISULPRIDE) · Acacia
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.